×
For best experience we recommend to activate Javascript in your browser.
Ferredoxin Reductase antibody (C-Term)
This anti-Ferredoxin Reductase antibody is a Rabbit Polyclonal antibody detecting Ferredoxin Reductase in WB and ELISA. Suitable for Human.
Quick Overview for Ferredoxin Reductase antibody (C-Term) (ABIN2265945)
Target
See all Ferredoxin Reductase (FDXR) Antibodies
Ferredoxin Reductase (FDXR)
Reactivity
All reactivities for Ferredoxin Reductase antibodies
Human
Host
All hosts for Ferredoxin Reductase antibodies
Rabbit
Clonality
All clonalities for Ferredoxin Reductase antibodies
Polyclonal
Conjugate
All conjugates for Ferredoxin Reductase antibodies
This Ferredoxin Reductase antibody is un-conjugated
Application
All applications for Ferredoxin Reductase antibodies
Western Blotting (WB), ELISA
Product Details anti-Ferredoxin Reductase Antibody
(hide)
Binding Specificity
All epitopes for Ferredoxin Reductase antibodies
AA 458-487, C-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
FDXR, CT (FDXR, ADXR, NADPH:adrenodoxin oxidoreductase, mitochondrial, Ferredoxin-NADP(+) reductase)
Purification
Purified by Protein A affinity chromatography.
Immunogen
FDXR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 458-487 amino acids from the C-terminal region of human FDXR.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for Ferredoxin Reductase
(hide)
Target
Ferredoxin Reductase (FDXR)
Alternative Name
FDXR
NCBI Accession
NP_077728 , NP_004101
UniProt
P22570
Recently viewed
(hide)
Chat with us , powered by LiveChat